S. Rothschild

Most-cited papers

1. Response to salvage chemotherapy following exposure to immune checkpoint inhibitors in patients with non-small cell lung cancer.

   P. Leger, S. Rothschild, E. Castellanos, R. Pillai +2 more

   201749 citations

   Semantic Scholar

   Save

2. 91PD_PRResponse to salvage chemotherapy following exposure to PD-1/PD-L1 inhibitors in patients with NSCLC

   S. Rothschild, P. Leger, E. Castellanos, R. Pillai +2 more

   20179 citations Open access

   Semantic Scholar

   Save

3. [Cancer immunotherapy - novel perspectives].

   S. Rothschild, A. Zippelius

   2012Therapeutische Umschau. Revue thérapeutique2 citations

   Semantic Scholar

   Save

4. Comprehensive characterization of PDL-1 and CTLA-4 in gastric cancer.

   H. Schloesser, U. Drebber, M. Thelen, M. Kloth +13 more

   20151 citations

   Semantic Scholar

   Save

5. [Chemotherapy for malignant tumors of lung and pleura].

   S. Rothschild, O. Gautschi

   2012Therapeutische Umschau. Revue thérapeutique1 citations

   Semantic Scholar

   Save

6. EP16.01-018 SAKK 16/14 -Peripheral Immune Cell Populations Inresponse to Neoadjuvant Durvalumab in Patients with Stage IIIA(N2) NSCLC

   D. Schmid, M. Trueb, P. Herzig, C. Gärtner-Pelham +14 more

   2022Journal of Thoracic Oncology0 citations Open access

   Semantic Scholar

   Save

7. MA12.04 SAKK 16/14: CD8 T Cell Positioning Correlates with Survivalin Stage IIIA(N2) NSCLC After Neoadjuvant Immunotherapy

   B. Sobottka, G. Tochtermann, M. Trueb, M. Nowack +17 more

   2022Journal of Thoracic Oncology0 citations Open access

   Semantic Scholar

   Save

8. P30.01 Extended Resections for Advanced Stages T3/T4 NSCLC After Neoadjuvant Treatment: Conclusions of SAKK Pooled Analysis (16/96, 16/00, 16/01)

   K. Furrer, W. Weder, E. Eboulet, D. Betticher +16 more

   2021Journal of Thoracic Oncology0 citations Open access

   Semantic Scholar

   Save

9. Impact of thrombophilia testing on treatment decision and outcome of thromboembolism and pregnancy morbidity : a single center retrospective cohort study

   S. Rothschild, I. Alborelli, K. Leonards, M. Manzo +16 more

   20210 citations

   Semantic Scholar

   Save

10. Can concomitant diseases predict the compliance with cisplatin plus RT in patients with LA SCCHN? An exploratory endpoint analysis of the COMPLY trial.

    J. Dunst, G. Hildebrandt, M. Becker-Schiebe, T. Kuhnt +7 more

    2018Annals of Oncology0 citations Open access

    Semantic Scholar

    Save

11. THE JAK1/2 INHIBITOR RUXOLITINIB MODULATES ANTIGEN PRESENTING FUNCTIONS OF ACTIVATED PRIMARY B CELLS ON A METABOLIC LEVEL

    S. Theurich, J. Iltgen, K. Wennhold, García Márquez +10 more

    20160 citations

    Semantic Scholar

    Save